Construction of si RNA expression vector of tissue inhibitor of metalloproteinases (TIMPs) and application in treatment of cirrhosis

A technology of inhibitor and expression vector, applied in the field of genetic engineering, can solve problems such as liver cirrhosis and liver fibrosis

Inactive Publication Date: 2011-01-26
CHONGQING MEDICAL UNIVERSITY
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is precisely because of the increase of TIMPs that ECM cannot be degraded by

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction of si RNA expression vector of tissue inhibitor of metalloproteinases (TIMPs) and application in treatment of cirrhosis
  • Construction of si RNA expression vector of tissue inhibitor of metalloproteinases (TIMPs) and application in treatment of cirrhosis
  • Construction of si RNA expression vector of tissue inhibitor of metalloproteinases (TIMPs) and application in treatment of cirrhosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026]According to the sequences of rat TIMP-1 and TIMP-2 genes in Genbank (accession numbers: NM_021578, NM_021989, AY550026), follow the siRNA design principle, select TIMP-1 coding region 297nt-317nt, TIMP-2 coding region 551nt-571nt nucleotide sequence, design the corresponding siRMA sequence, and perform BLAST comparison to avoid homology with other genes. Chemically synthesized single-stranded oligonucleotides, annealed in vitro to form double-stranded DNA, and ligated with eukaryotic expression vector pGeneil-1, enzyme digestion identification and sequence analysis showed that two genes targeting TIMP-1 and TIMP-2 were successfully constructed Sequence of siRNA expression vectors. After the above expression vectors were transfected into hepatic stellate cells HSC-T6 through cationic liposomes, they could significantly inhibit the mRNA expression of TIMP-1 and TIMP-2; injecting them into animal models of liver cirrhosis by hydrodynamic method could significantly reduce t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses the construction of a si RNA expression vector of the tissue inhibitor of metalloproteinases (TIMPs) and application in treatment of cirrhosis, which belong to the technical field of genetic engineering. In the invention, according to the design principle of siRNA, a corresponding si RNA sequence is designed by selecting nucleotide sequences of TIMP-1 and TIMP-2 coding areas respectively to perform BLAST comparison, so that isogenesis with other genes is avoided; single-stranded oligonucleotides chemically synthesized and the double stranded DNA formed by annealing in vitro are connected with a eukaryotic expression vector pGeneil-1; and enzyme digesting identification and sequence assay prove that the si RNA expression vector of the TIMP-1 and TIMP-2 is constructed successfully. The vector transfects a hepatic stellate cell (HSC) through liposome and can inhibit the expression of the TIMP-1 and the TIMP-2 obviously; cirrhosis animal model assay shows that the expression vector can reduce the collagenous fiber deposition of liver tissues considerably and is expected to be used as a novel anti-hepatic fibrosis genetic therapy in clinical treatment.

Description

Technical field: [0001] The invention belongs to the technical field of genetic engineering Background technique: [0002] Traditional gene therapy (gene therapy) is a treatment method that uses normal or wild type (wild type) genes to correct or replace disease-causing genes. In this treatment method, the target gene is introduced into the target cells, and they either integrate with the host cell chromosome to become part of the host genetic material, or do not integrate with the chromosome and are located outside the chromosome, but both It can be expressed in cells and play a role in treating diseases. At present, the concept of gene therapy has been greatly expanded. Any disease treatment method carried out at the nucleic acid level using the methods and principles of molecular biology can be called gene therapy. With the in-depth understanding of the nature of the disease and the continuous emergence of new molecular biology methods, gene therapy has made great progr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/85A61K48/00A61P1/16
Inventor 石小枫刘杞徐宁郎清钱克莉戚敬虎
Owner CHONGQING MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products